119216-89-6

Upstream product

• 119216-95-4 methyl (Z)-7-{(1S,2R,4R)-4-methyl-2-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-3,5-dioxanyl}hept-5-enoate 
• 119252-61-8 (Z)-7-{(1S,2R,4R)-4-methyl-2-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-3,5-dioxanyl}hept-5-enoic acid 
• 119216-93-2 ethyl (1S,2R,4R)-{4-methyl-2-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-3,5-dioxanyl}acetate 
• 70369-46-9 (2R,4S,5R)-4-hydroxymethyl-2-methyl-1,3-dioxan-5-ol 
• 103-71-9 phenyl isocyanate 
• 119216-96-5 methyl (Z)-7-((1S,2R,4R)-2-hydroxymethyl-4-methyl-3,5-dioxanyl)hept-5-enoate 
• 70377-89-8 (1'R)-(-)-2,4-O-ethylidene-D-erythrose 
• 18465-50-4 4,6-O-ethylidene-D-glucopyranose 
• 119216-92-1 ethyl (2R,4R)-{4-methyl-2-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-3,5-dioxanylidene}acetate 
• 119216-94-3 (1S,2R,4R)-{4-methyl-2-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-3,5-dioxanyl}ethanal 
• 119216-90-9 (2R,4S,5R)-2-methyl-4-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-1,3-dioxan-5-ol 
• 127890-78-2 (2R,4S)-2-methyl-4-[(1,1,2,2-tetramethyl-1-silapropoxy)methyl]-1,3-dioxan-5-one 

Relevant academic research and scientific papers

Synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane A2 receptor antagonists

The synthesis and biological activity of novel 4-methyl-3,5-dioxane analogues are described. All compounds were produced through modification of the substituent formally corresponding to the ω-octenol side chain of thromboxane A2 (TXA2/su

Oxygen-containing heterocyclic compound

The invention relates to treatment of diseases caused by thromboxane A2 comprising administering a compound STR1 wherein R1 is hydrogen or lower alkyl, R2 is carboxy(lower)alkyl or protected carboxy(lower)alkyl and R3

Oxygen-containing hererocyclic compound, processes for their preparation and pharmaceutical compositions comprising them

A compound of the formula : wherein, R1 is hydrogen or lower alkyl,R2 is carboxy(lower)alkyl or protected carboxy(lower)alkyl and, R3 is -CH2NH-R4, -CH=N-R4 or -CH2-R5, in which, R4 is acyl